NM_005022.4:c.341T>C
Variant summary
Our verdict is Pathogenic. The variant received 10 ACMG points: 10P and 0B. PM2PM5PP3_StrongPP5_Moderate
The NM_005022.4(PFN1):c.341T>C(p.Met114Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M114R) has been classified as Likely pathogenic.
Frequency
Consequence
NM_005022.4 missense
Scores
Clinical Significance
Conservation
Publications
- amyotrophic lateral sclerosis type 18Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen, Genomics England PanelApp
- amyotrophic lateral sclerosisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 10 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 29
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Amyotrophic lateral sclerosis type 18 Pathogenic:1
- -
not provided Pathogenic:1
For these reasons, this variant has been classified as Pathogenic. This sequence change replaces methionine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 114 of the PFN1 protein (p.Met114Thr). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with amyotrophic lateral sclerosis (PMID: 22801503). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 37035). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. Experimental studies have shown that this missense change affects PFN1 function (PMID: 22801503). -
PFN1-related disorder Pathogenic:1
The PFN1 c.341T>C variant is predicted to result in the amino acid substitution p.Met114Thr. This variant was reported in an individual(s) with amyotrophic lateral sclerosis (Wu et al. 2012. PubMed ID: 22801503; Corcia et al. 2021. PubMed ID: 33408239). In vitro assays showed p.Met114Thr promotes the formation of PFN1 aggregates and impacts its function (Tanaka et al. 2016. PubMed ID: 26908597). An in vivo fruit fly model suggested the variant may exert a loss-of-function mechanism (Wu et al. 2017. PubMed ID: 28379367) though other studies have suggested a gain-of-function mechanism via formin-induced actin polymerization ultimately resulting in neurodegeneration (Schmidt et al. 2021. PubMed ID: 34074767; Liu et al. 2022. PubMed ID: 35248815) This variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. This variant is interpreted as pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at